{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:22:32Z","timestamp":1761988952309},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1038\/eye.2016.43","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T10:32:12Z","timestamp":1458297132000},"page":"877-887","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy"],"prefix":"10.1038","volume":"30","author":[{"given":"G","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,18]]},"reference":[{"issue":"1","key":"BFeye201643_CR1","first-page":"23","volume":"86","author":"J Folkman","year":"2001","unstructured":"Folkman J, Browder T, Palmblad J . Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost 2001; 86 (1): 23\u201333.","journal-title":"Thromb Haemost"},{"issue":"3","key":"BFeye201643_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP . Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 1998; 43 (3): 245\u2013269.","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"BFeye201643_CR3","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1001\/archopht.1995.01100120068012","volume":"113","author":"LP Aiello","year":"1995","unstructured":"Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA . Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995; 113 (12): 1538\u20131544.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"BFeye201643_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/152091599317396","volume":"1","author":"V Petrovic","year":"1999","unstructured":"Petrovic V, Bhisitkul RB . Lasers and diabetic retinopathy: the art of gentle destruction. Diabetes Technol Ther 1999; 1 (2): 177\u2013187.","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"BFeye201643_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3928\/15428877-20120426-05","volume":"43","author":"CK Sramek","year":"2012","unstructured":"Sramek CK, Leung LS, Paulus YM, Palanker DV . Therapeutic window of retinal photocoagulation with green (532-nm) and yellow (577-nm) lasers. Ophthalmic Surg Lasers Imaging 2012; 43 (4): 341\u2013347.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"8","key":"BFeye201643_CR6","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1517\/13543784.16.8.1209","volume":"16","author":"C Hernandez","year":"2007","unstructured":"Hernandez C, Simo R . Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice. Expert Opin Investig Drugs 2007; 16 (8): 1209\u20131226.","journal-title":"Expert Opin Investig Drugs"},{"issue":"7","key":"BFeye201643_CR7","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00417-010-1315-z","volume":"248","author":"BP Nicholson","year":"2010","unstructured":"Nicholson BP, Schachat AP . A review of clinical trials of anti-VEGF agents for diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2010; 248 (7): 915\u2013930.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"BFeye201643_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.2353\/ajpath.2010.090526","volume":"176","author":"K Boye","year":"2010","unstructured":"Boye K, Maelandsmo GM . S100A4 and metastasis: a small actor playing many roles. Am J Pathol 2010; 176 (2): 528\u2013535.","journal-title":"Am J Pathol"},{"issue":"4","key":"BFeye201643_CR9","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1158\/1078-0432.CCR-05-1580","volume":"12","author":"S de Silva Rudland","year":"2006","unstructured":"de Silva Rudland S, Martin L, Roshanlall C, Winstanley J, Leinster S, Platt-Higgins A et al. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. Clin Cancer Res 2006; 12 (4): 1192\u20131200.","journal-title":"Clin Cancer Res"},{"issue":"34","key":"BFeye201643_CR10","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1038\/sj.onc.1204636","volume":"20","author":"N Ambartsumian","year":"2001","unstructured":"Ambartsumian N, Klingelhofer J, Grigorian M, Christensen C, Kriajevska M, Tulchinsky E et al. The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor. Oncogene 2001; 20 (34): 4685\u20134695.","journal-title":"Oncogene"},{"issue":"32","key":"BFeye201643_CR11","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1038\/sj.onc.1207720","volume":"23","author":"B Schmidt-Hansen","year":"2004","unstructured":"Schmidt-Hansen B, Ornas D, Grigorian M, Klingelhofer J, Tulchinsky E, Lukanidin E et al. Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity. Oncogene 2004; 23 (32): 5487\u20135495.","journal-title":"Oncogene"},{"issue":"6","key":"BFeye201643_CR12","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00425-014-2054-x","volume":"239","author":"ZJ Zhang","year":"2014","unstructured":"Zhang ZJ . Artificial trans-acting small interfering RNA: a tool for plant biology study and crop improvements. Planta 2014; 239 (6): 1139\u20131146.","journal-title":"Planta"},{"issue":"11","key":"BFeye201643_CR13","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"KM Connor","year":"2009","unstructured":"Connor KM, Krah NM, Dennison RJ, Aderman CM, Chen J, Guerin KI et al. Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 2009; 4 (11): 1565\u20131573.","journal-title":"Nat Protoc"},{"key":"BFeye201643_CR14","first-page":"492","volume":"17","author":"X Zhong","year":"2011","unstructured":"Zhong X, Huang H, Shen J, Zacchigna S, Zentilin L, Giacca M et al. Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation. Mol Vis 2011; 17: 492\u2013507.","journal-title":"Mol Vis"},{"key":"BFeye201643_CR15","doi-asserted-by":"crossref","unstructured":"Chiu K, Chang RC, So KF . Intravitreous injection for establishing ocular diseases model. J Vis Exp 2007; (8): 313.","DOI":"10.3791\/313"},{"issue":"1","key":"BFeye201643_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.acthis.2012.03.005","volume":"115","author":"W Fan","year":"2013","unstructured":"Fan W, Xing Y, Zhong Y, Chen C, Shen Y . Expression of NMDA receptor subunit 1 in the rat retina. Acta Histochem 2013; 115 (1): 42\u201347.","journal-title":"Acta Histochem"},{"issue":"3","key":"BFeye201643_CR17","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jphs.2015.02.008","volume":"127","author":"Y Koriyama","year":"2015","unstructured":"Koriyama Y, Hisano S, Ogai K, Sugitani K, Furukawa A, Kato S . Involvement of neuronal nitric oxide synthase in N-methyl-N-nitrosourea-induced retinal degeneration in mice. J Pharmacol Sci 2015; 127 (3): 394\u2013396.","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"BFeye201643_CR18","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994; 35 (1): 101\u2013111.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye201643_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.exer.2013.12.019","volume":"121","author":"YY Chen","year":"2014","unstructured":"Chen YY, Liu SL, Hu DP, Xing YQ, Shen Y . N-methyl-N-nitrosourea-induced retinal degeneration in mice. Exp Eye Res 2014; 121: 102\u2013113.","journal-title":"Exp Eye Res"},{"issue":"4","key":"BFeye201643_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25 (4): 402\u2013408.","journal-title":"Methods"},{"issue":"1","key":"BFeye201643_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.biocel.2009.10.006","volume":"42","author":"P Sapieha","year":"2010","unstructured":"Sapieha P, Hamel D, Shao Z, Rivera JC, Zaniolo K, Joyal JS et al. Proliferative retinopathies: angiogenesis that blinds. Int J Biochem Cell Biol 2010; 42 (1): 5\u201312.","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"BFeye201643_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","volume":"27","author":"JS Penn","year":"2008","unstructured":"Penn JS, Madan A, Caldwell RB, Bartoli M, Caldwell RW, Hartnett ME . Vascular endothelial growth factor in eye disease. Prog Retin Eye Res 2008; 27 (4): 331\u2013371.","journal-title":"Prog Retin Eye Res"},{"key":"BFeye201643_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0065-2423(10)50006-4","volume":"50","author":"M Rajappa","year":"2010","unstructured":"Rajappa M, Saxena P, Kaur J . Ocular angiogenesis: mechanisms and recent advances in therapy. Adv Clin Chem 2010; 50: 103\u2013121.","journal-title":"Adv Clin Chem"},{"issue":"6","key":"BFeye201643_CR24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/jemt.10296","volume":"60","author":"R Donato","year":"2003","unstructured":"Donato R . Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003; 60 (6): 540\u2013551.","journal-title":"Microsc Res Tech"},{"issue":"25","key":"BFeye201643_CR25","doi-asserted-by":"publisher","first-page":"22699","DOI":"10.1074\/jbc.M010231200","volume":"276","author":"M Grigorian","year":"2001","unstructured":"Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1\/S100A4 protein: functional consequences of their interaction. J Biol Chem 2001; 276 (25): 22699\u201322708.","journal-title":"J Biol Chem"},{"issue":"11","key":"BFeye201643_CR26","first-page":"4234","volume":"6","author":"Y Yonemura","year":"2000","unstructured":"Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K et al. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 2000; 6 (11): 4234\u20134242.","journal-title":"Clin Cancer Res"},{"issue":"12 Pt 1","key":"BFeye201643_CR27","first-page":"2309","volume":"3","author":"K Takenaga","year":"1997","unstructured":"Takenaga K, Nakanishi H, Wada K, Suzuki M, Matsuzaki O, Matsuura A et al. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res 1997; 3 (12 Pt 1): 2309\u20132316.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"BFeye201643_CR28","first-page":"1595","volume":"60","author":"PS Rudland","year":"2000","unstructured":"Rudland PS, Platt-Higgins A, Renshaw C, West CR, Winstanley JH, Robertson L et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res 2000; 60 (6): 1595\u20131603.","journal-title":"Cancer Res"},{"issue":"1","key":"BFeye201643_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0002-9440(10)64347-7","volume":"160","author":"C Rosty","year":"2002","unstructured":"Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 2002; 160 (1): 45\u201350.","journal-title":"Am J Pathol"},{"issue":"5","key":"BFeye201643_CR30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00417-011-1912-5","volume":"250","author":"J Kim","year":"2012","unstructured":"Kim J, Kim CS, Lee YM, Jo K, Shin SD, Kim JS . Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases. Graefes Arch Clin Exp Ophthalmol 2012; 250 (5): 691\u2013697.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"BFeye201643_CR31","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1167\/iovs.11-8311","volume":"53","author":"S Peng","year":"2012","unstructured":"Peng S, Gan G, Rao VS, Adelman RA, Rizzolo LJ . Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2012; 53 (8): 5016\u20135028.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"BFeye201643_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10456-013-9372-7","volume":"17","author":"T Ochiya","year":"2014","unstructured":"Ochiya T, Takenaga K, Endo H . Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth. Angiogenesis 2014; 17 (1): 17\u201326.","journal-title":"Angiogenesis"},{"key":"BFeye201643_CR33","first-page":"2225","volume":"16","author":"C Li","year":"2010","unstructured":"Li C, Zhang F, Wang Y . S100A proteins in the pathogenesis of experimental corneal neovascularization. Mol Vis 2010; 16: 2225\u20132235.","journal-title":"Mol Vis"},{"key":"BFeye201643_CR34","first-page":"1209","volume":"20","author":"AM Abu El-Asrar","year":"2014","unstructured":"Abu El-Asrar AM, Nawaz MI, De Hertogh G, Alam K, Siddiquei MM, Van den Eynde K et al. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis. Mol Vis 2014; 20: 1209\u20131224.","journal-title":"Mol Vis"},{"issue":"4","key":"BFeye201643_CR35","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/path.2611","volume":"219","author":"Y Bai","year":"2009","unstructured":"Bai Y, Ma JX, Guo J, Wang J, Zhu M, Chen Y et al. Muller cell-derived VEGF is a significant contributor to retinal neovascularization. J Pathol 2009; 219 (4): 446\u2013454.","journal-title":"J Pathol"},{"issue":"9","key":"BFeye201643_CR36","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1016\/j.biomaterials.2013.12.031","volume":"35","author":"DH Jo","year":"2014","unstructured":"Jo DH, Kim S, Kim D, Kim JH, Jon S, Kim JH . VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization. Biomaterials 2014; 35 (9): 3052\u20133059.","journal-title":"Biomaterials"},{"issue":"11","key":"BFeye201643_CR37","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.2337\/db13-0014","volume":"62","author":"M Rodrigues","year":"2013","unstructured":"Rodrigues M, Xin X, Jee K, Babapoor-Farrokhran S, Kashiwabuchi F, Ma T et al. VEGF secreted by hypoxic Muller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes 2013; 62 (11): 3863\u20133873.","journal-title":"Diabetes"},{"issue":"9","key":"BFeye201643_CR38","doi-asserted-by":"publisher","first-page":"e72480","DOI":"10.1371\/journal.pone.0072480","volume":"8","author":"JL Hernandez","year":"2013","unstructured":"Hernandez JL, Padilla L, Dakhel S, Coll T, Hervas R, Adan J et al. Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody. PLoS One 2013; 8 (9): e72480.","journal-title":"PLoS One"},{"issue":"21","key":"BFeye201643_CR39","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1242\/dev.127.21.4531","volume":"127","author":"MJ Donovan","year":"2000","unstructured":"Donovan MJ, Lin MI, Wiegn P, Ringstedt T, Kraemer R, Hahn R et al. Brain derived neurotrophic factor is an endothelial cell survival factor required for intramyocardial vessel stabilization. Development 2000; 127 (21): 4531\u20134540.","journal-title":"Development"},{"issue":"3","key":"BFeye201643_CR40","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1172\/JCI200522655","volume":"115","author":"P Kermani","year":"2005","unstructured":"Kermani P, Rafii D, Jin DK, Whitlock P, Schaffer W, Chiang A et al. Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest 2005; 115 (3): 653\u2013663.","journal-title":"J Clin Invest"},{"issue":"8","key":"BFeye201643_CR41","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1158\/0008-5472.CAN-05-2789","volume":"66","author":"K Nakamura","year":"2006","unstructured":"Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, Thiele CJ . Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res 2006; 66 (8): 4249\u20134255.","journal-title":"Cancer Res"},{"issue":"4","key":"BFeye201643_CR42","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.bcp.2014.08.008","volume":"91","author":"CY Lin","year":"2014","unstructured":"Lin CY, Hung SY, Chen HT, Tsou HK, Fong YC, Wang SW et al. Brain-derived neurotrophic factor increases vascular endothelial growth factor expression and enhances angiogenesis in human chondrosarcoma cells. Biochem Pharmacol 2014; 91 (4): 522\u2013533.","journal-title":"Biochem Pharmacol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye201643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201643","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye201643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:29:43Z","timestamp":1684430983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye201643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,18]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["BFeye201643"],"URL":"https:\/\/doi.org\/10.1038\/eye.2016.43","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,18]]},"assertion":[{"value":"26 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}